[Expression of IL6 and TNF-alpha in normal and pathological kidney].

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Comptes rendus des seances de la Societe de biologie et de ses filiales

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8019918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-6 and renal cell cancer: Production, regulation, and growth effects

  2005cited by this paper
• In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis.

  1993cited by this paper
• Interleukin-6 and TNF alpha production in human renal cell carcinoma.

  1993cited by this paper
• Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.

  1993cited by this paper
• Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.

  1993cited by this paper
• Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro.

  1993cited by this paper
• Tumor necrosis factor alpha and mesangial cells.

  1992cited by this paper
• Interleukin-6: an autocrine regulator of mesangial cell growth.

  1992cited by this paper
• IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells.

  1992cited by this paper
• Differential in situ expression of cytokines in renal allograft rejection.

  1991cited by this paper
• Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.

  1991cited by this paper
• Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha.

  1991cited by this paper
• Distribution of interleukin-6 in normal and diseased human kidney.

  1991cited by this paper
• Cytokines in context

  1991cited by this paper
• MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells.

  1990cited by this paper
• IgG1 plasmacytosis in interleukin 6 transgenic mice.

  1989cited by this paper
• Interleukins and the immune system 1.

  1989cited by this paper
• IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

  1989cited by this paper
• Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas

  1989cited by this paper
• Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide.

  1989cited by this paper
• Involvement of IL-6 in mesangial proliferative glomerulonephritis.

  1989cited by this paper
• Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals.

  1988cited by this paper
• Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

  1987cited by this paper

• TNF receptors: signaling pathways and contribution to renal dysfunction.

  2015cites this paper
• Tumour Necrosis Factor – Misnomer and Therapeutic Target

  2009cites this paper
• GM 1 and Tumor Necrosis Factor-A , Overexpressed in Renal Cell Carcinoma , Synergize to Induce T-Cell Apoptosis

  2008cites this paper
• GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.

  2008cites this paper
• Undernutrition in elderly patients with cancer: target for diagnosis and intervention.

  2008cites this paper
• Expression of Tumor Necrosis Factor Receptors in Normal Kidney and Rejecting Renal Transplants

  2001cites this paper
• Control of hepatic parameters in renal cell carcinoma (RCC) by interleukin-6 (IL-6)?

  1999cites this paper